

Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, has raised $105 million in Series B financing. Lightchain Capital and NT Investments led the round.
Source: Press Release
Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, has raised $105 million in Series B financing.
Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, has raised $105 million in Series B financing. Lightchain Capital and NT Investments led the round.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination